General Information of the Compound
| Compound ID |
CP0692272
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(4-(7-((3,5-dimethoxyphenyl)(3-(isopropylamino)propyl)amino)quinoxalin-2-yl)-1H-pyrazol-1-yl)-N-methylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H35N7O3
|
||||||||||||||||||
| Molecular Weight |
517.634
|
||||||||||||||||||
| Canonical SMILES |
CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H35N7O3/c1-19(2)30-9-6-10-35(22-11-23(37-4)14-24(12-22)38-5)21-7-8-25-26(13-21)33-27(16-31-25)20-15-32-34(17-20)18-28(36)29-3/h7-8,11-17,19,30H,6,9-10,18H2,1-5H3,(H,29,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PXRZIWUUBMUSOA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01411, Fibroblast growth factor receptor 3
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT00864, Vascular endothelial growth factor receptor 2